137 related articles for article (PubMed ID: 9987671)
1. Molecular genetics of ovarian carcinomas.
Diebold J
Histol Histopathol; 1999 Jan; 14(1):269-77. PubMed ID: 9987671
[TBL] [Abstract][Full Text] [Related]
2. [Molecular genetics of epithelial ovarian neoplasms: correlations with phenotype and biological behavior].
Diebold J
Pathologe; 1998 Feb; 19(2):95-103. PubMed ID: 9556793
[TBL] [Abstract][Full Text] [Related]
3. Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumours.
Evans MF; McDicken IW; Herrington CS
J Pathol; 1999 Sep; 189(1):53-9. PubMed ID: 10451488
[TBL] [Abstract][Full Text] [Related]
4. Interphase cytogenetic analysis of serous ovarian tumors of low malignant potential: comparison with serous cystadenomas and invasive serous carcinomas.
Diebold J; Deisenhofer I; Baretton GB; Blasenbreu S; Suchy B; Schneiderbanger K; Meier W; Haas CJ; Löhrs U
Lab Invest; 1996 Oct; 75(4):473-85. PubMed ID: 8874380
[TBL] [Abstract][Full Text] [Related]
5. Interphase cytogenetic analysis of mucinous ovarian neoplasms.
Diebold J; Siegert S; Baretton GB; Suchy B; Meier W; Haas CJ; Löhrs U
Lab Invest; 1997 May; 76(5):661-70. PubMed ID: 9166285
[TBL] [Abstract][Full Text] [Related]
6. In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours.
Sieben NL; Macropoulos P; Roemen GM; Kolkman-Uljee SM; Jan Fleuren G; Houmadi R; Diss T; Warren B; Al Adnani M; De Goeij AP; Krausz T; Flanagan AM
J Pathol; 2004 Mar; 202(3):336-40. PubMed ID: 14991899
[TBL] [Abstract][Full Text] [Related]
7. Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.
Rambau PF; McIntyre JB; Taylor J; Lee S; Ogilvie T; Sienko A; Morris D; Duggan MA; McCluggage WG; Köbel M
Am J Surg Pathol; 2017 May; 41(5):685-695. PubMed ID: 28125452
[TBL] [Abstract][Full Text] [Related]
8. The gene copy number of c-MET has a significant impact on progression-free survival in Korean patients with ovarian carcinoma.
Kim WY; Shim SH; Jung HY; Dong M; Kim SN; Lee SJ
Hum Pathol; 2017 Jun; 64():98-105. PubMed ID: 28428108
[TBL] [Abstract][Full Text] [Related]
9. Microsatellite analysis in serous tumors of the ovary.
Haas CJ; Diebold J; Hirschmann A; Rohrbach H; Schmid S; Löhrs U
Int J Gynecol Pathol; 1999 Apr; 18(2):158-62. PubMed ID: 10202674
[TBL] [Abstract][Full Text] [Related]
10. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.
Obata K; Morland SJ; Watson RH; Hitchcock A; Chenevix-Trench G; Thomas EJ; Campbell IG
Cancer Res; 1998 May; 58(10):2095-7. PubMed ID: 9605750
[TBL] [Abstract][Full Text] [Related]
11. Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics.
Prat J; D'Angelo E; Espinosa I
Hum Pathol; 2018 Oct; 80():11-27. PubMed ID: 29944973
[TBL] [Abstract][Full Text] [Related]
12. [Phenotype--genotype--correlation in ovarian neoplasia].
Diebold J
Verh Dtsch Ges Pathol; 2001; 85():153-60. PubMed ID: 11894392
[TBL] [Abstract][Full Text] [Related]
13. KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.
Mayr D; Hirschmann A; Löhrs U; Diebold J
Gynecol Oncol; 2006 Dec; 103(3):883-7. PubMed ID: 16806438
[TBL] [Abstract][Full Text] [Related]
14. [Molecular carcinogenesis of ovarian carcinoma].
Diebold J
Verh Dtsch Ges Pathol; 2005; 89():77-83. PubMed ID: 18035676
[TBL] [Abstract][Full Text] [Related]
15. Molecular pathology of ovarian cancer.
Sanseverino F; D'Andrilli G; Petraglia F; Giordano A
Anal Quant Cytol Histol; 2005 Jun; 27(3):121-4. PubMed ID: 16121632
[TBL] [Abstract][Full Text] [Related]
16. Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas.
Tapper J; Bützow R; Wahlström T; Seppälä M; Knuutila S
Br J Cancer; 1997; 75(12):1782-7. PubMed ID: 9192982
[TBL] [Abstract][Full Text] [Related]
17. Expression and mutational analysis of c-kit in ovarian surface epithelial tumors.
Kim DJ; Lee MH; Park TI; Bae HI
J Korean Med Sci; 2006 Feb; 21(1):81-5. PubMed ID: 16479070
[TBL] [Abstract][Full Text] [Related]
18. Frameshift mutations in the bax gene are not involved in development of ovarian endometrioid carcinoma.
Cao SN; Chang KH; Luthra R; Liu J
Mod Pathol; 2003 Oct; 16(10):1048-52. PubMed ID: 14559989
[TBL] [Abstract][Full Text] [Related]
19. Expression of extracellular matrix proteins in ovarian serous tumors.
Salani R; Neuberger I; Kurman RJ; Bristow RE; Chang HW; Wang TL; Shih IeM
Int J Gynecol Pathol; 2007 Apr; 26(2):141-6. PubMed ID: 17413980
[TBL] [Abstract][Full Text] [Related]
20. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
McCluggage WG
Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
